Basically, a mutation database (MDB) is a repository where allelic variations are described and assigned within a specific gene locus. The purposes of an MDB may vary greatly and have different content and structure. The curator of an electronic and computer‐based MDB will provide expert feedback (clinical and research). This requires ethical guideposts. Going to direct on‐line public access for the content of an MDB or to interactive communication also raises other considerations. Currently, HUGO's MDI (Mutation Database Initiative) is the only integrated effort supporting and guiding the coordinated deployment of MDBs devoted to genetic diversity. Thus, HUGO's ethical “Statements” are applicable. Among the ethical principles, the obligation of preserving the confidentiality of information transferred by a collaborator to the curator is particularly important. Thus, anonymization of such data prior to transmission is essential. The 1997 Universal Declaration on the Human Genome and Human Rights of UNESCO addresses the participation of vulnerable persons. Researchers in charge of MDBs should ensure that information received on the testing of children or incompetent adults is subject to ethical review and approval in the country of origin. Caution should be taken against the involuntary consequences of public disclosure of results without complete explanation. Clear and enforceable regulations must be developed to protect the public against misuse of genetic databanks. Interaction with a databank could be seen as creating a “virtual” physician–patient relationship. However, interactive public MDBs should not give medical advice. We have identified new social ethical principles to govern different levels of complexity of genetic information. They are: reciprocity, mutuality, solidarity, and universality. Finally, precaution and prudence at this early stage of the MDI may not only avoid ethically inextricable conundrums but also provide for the respect for the rights and interests of all those involved. Hum Mutat 15:30–35, 2000. © 2000 Wiley‐Liss, Inc.
[1]
C R Scriver,et al.
Guidelines and recommendations for content, structure, and deployment of mutation databases: II. Journey in progress
,
2000,
Human mutation.
[2]
M. W. Foster,et al.
The role of community review in evaluating the risks of human genetic variation research.
,
1999,
American journal of human genetics.
[3]
H. Lehväslaiho,et al.
Guidelines and recommendations for content, structure, and deployment of mutation databases
,
1999,
Human mutation.
[4]
H. Greely,et al.
Genomics Research and Human Subjects
,
1998,
Science.
[5]
B. Knoppers,et al.
Control of DNA samples and information.
,
1998,
Genomics.
[6]
B. Knoppers,et al.
Bioethics for clinicians: 14. Ethics and genetics in medicine.
,
1998,
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[7]
B. Knoppers,et al.
Ethical issues in international collaborative research on the human genome: The HGP and the HGDP
,
1996
.
[8]
T. W. Richards.
Oeuvres Complétes de J.C. Galissard de Marignac: Hors-série Mémoires de la Société de Physique et d'Histoire Naturelle de Genèeve
,
1903
.